Dr Alex J Makalinao, MD - Medicare Hematology/oncology in Las Vegas, NV

Dr Alex J Makalinao, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Las Vegas, Nevada. He graduated from medical school in 1986 and has 38 years of diverse experience with area of expertise as Hematology/oncology. He is a member of the group practice Optum Medical Group Rhodes P C and his current practice location is 2300 W Charleston Blvd, Las Vegas, Nevada. You can reach out to his office (for appointments etc.) via phone at (310) 649-7222.

Dr Alex J Makalinao is licensed to practice in Nevada (license number 20496) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1598790602.

Contact Information

Dr Alex J Makalinao, MD
2300 W Charleston Blvd,
Las Vegas, NV 89102-2149
(310) 649-7222
Not Available



Physician's Profile

Full NameDr Alex J Makalinao
GenderMale
SpecialityHematology/oncology
Experience38 Years
Location2300 W Charleston Blvd, Las Vegas, Nevada
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Alex J Makalinao graduated from medical school in 1986
  NPI Data:
  • NPI Number: 1598790602
  • Provider Enumeration Date: 07/11/2006
  • Last Update Date: 02/21/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 4082897210
  • Enrollment ID: I20210115001872

Medical Identifiers

Medical identifiers for Dr Alex J Makalinao such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1598790602NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RH0003XInternal Medicine - Hematology & Oncology 20496 (Nevada)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Optum Medical Group Rhodes P C105239003662

News Archive

23andMe project aims at validating highly scalable pharmacogenomics research

23andMe has launched a project funded by the National Institutes of Health which is aimed at validating 23andMe's highly-scalable platform for pharmacogenomics research. The company received $190,000 in stimulus funding from the American Recovery and Reinvestment Act of 2009 for "Web-based Phenotyping for Genome-Wide Association Studies of Drug Response" from NIH's National Human Genome Research Institute.

LensAR receives patent for using laser technology to increase flexibility of ocular lens

LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced the issuance of United States patent 7,655,002. This patent addresses methods for using laser technology to increase the flexibility of the ocular lens in order to both restore accommodation in presbyopia patients and allow easier removal of hardened lenses in cataract patients.

MAKO Surgical second-quarter total revenue increases 151% to $10.3 million

MAKO Surgical Corp., a medical device company that markets both its RIO® Robotic Arm Interactive Orthopedic surgical platform and proprietary RESTORIS® implants for minimally invasive orthopedic knee procedures known as MAKOplasty®, today announced its operating results for its second quarter ended June 30, 2010.

Researchers analyze benefits of platelet-rich plasma therapy for tennis elbow

A procedure intended to help heal musculoskeletal injuries called platelet-rich plasma therapy, or P.R.P., has created a big buzz in sports medicine and the media in recent years. Tiger Woods reportedly received the procedure for a sore knee and Pittsburgh Steelers' Hines Ward used it for a sprained knee ligament just before playing a key role in the team's 2009 Super Bowl victory.

Study explores role of proline containing peptides in inhibiting anti-apoptotic function of XIAP

Basic and translational research on cancer, and development of new cancer therapeutics, has focused on different aspects of cancer cellular function. One area of focus is the life and death of a cancer cell. Apoptosis, also known as programmed cell death, is a fundamental process of cells including cancer cells. The signal transduction pathways of apoptosis involve many different proteins and their interactions with each other.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Alex J Makalinao allows following entities to bill medicare on his behalf.
Entity NameOptum Medical Group Rhodes P C
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063458594
PECOS PAC ID: 1052390036
Enrollment ID: O20040714000813

News Archive

23andMe project aims at validating highly scalable pharmacogenomics research

23andMe has launched a project funded by the National Institutes of Health which is aimed at validating 23andMe's highly-scalable platform for pharmacogenomics research. The company received $190,000 in stimulus funding from the American Recovery and Reinvestment Act of 2009 for "Web-based Phenotyping for Genome-Wide Association Studies of Drug Response" from NIH's National Human Genome Research Institute.

LensAR receives patent for using laser technology to increase flexibility of ocular lens

LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced the issuance of United States patent 7,655,002. This patent addresses methods for using laser technology to increase the flexibility of the ocular lens in order to both restore accommodation in presbyopia patients and allow easier removal of hardened lenses in cataract patients.

MAKO Surgical second-quarter total revenue increases 151% to $10.3 million

MAKO Surgical Corp., a medical device company that markets both its RIO® Robotic Arm Interactive Orthopedic surgical platform and proprietary RESTORIS® implants for minimally invasive orthopedic knee procedures known as MAKOplasty®, today announced its operating results for its second quarter ended June 30, 2010.

Researchers analyze benefits of platelet-rich plasma therapy for tennis elbow

A procedure intended to help heal musculoskeletal injuries called platelet-rich plasma therapy, or P.R.P., has created a big buzz in sports medicine and the media in recent years. Tiger Woods reportedly received the procedure for a sore knee and Pittsburgh Steelers' Hines Ward used it for a sprained knee ligament just before playing a key role in the team's 2009 Super Bowl victory.

Study explores role of proline containing peptides in inhibiting anti-apoptotic function of XIAP

Basic and translational research on cancer, and development of new cancer therapeutics, has focused on different aspects of cancer cellular function. One area of focus is the life and death of a cancer cell. Apoptosis, also known as programmed cell death, is a fundamental process of cells including cancer cells. The signal transduction pathways of apoptosis involve many different proteins and their interactions with each other.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Alex J Makalinao is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Alex J Makalinao, MD
Po Box 35380,
Las Vegas, NV 89133-5380

Ph: (310) 251-4471
Dr Alex J Makalinao, MD
2300 W Charleston Blvd,
Las Vegas, NV 89102-2149

Ph: (310) 649-7222

News Archive

23andMe project aims at validating highly scalable pharmacogenomics research

23andMe has launched a project funded by the National Institutes of Health which is aimed at validating 23andMe's highly-scalable platform for pharmacogenomics research. The company received $190,000 in stimulus funding from the American Recovery and Reinvestment Act of 2009 for "Web-based Phenotyping for Genome-Wide Association Studies of Drug Response" from NIH's National Human Genome Research Institute.

LensAR receives patent for using laser technology to increase flexibility of ocular lens

LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced the issuance of United States patent 7,655,002. This patent addresses methods for using laser technology to increase the flexibility of the ocular lens in order to both restore accommodation in presbyopia patients and allow easier removal of hardened lenses in cataract patients.

MAKO Surgical second-quarter total revenue increases 151% to $10.3 million

MAKO Surgical Corp., a medical device company that markets both its RIO® Robotic Arm Interactive Orthopedic surgical platform and proprietary RESTORIS® implants for minimally invasive orthopedic knee procedures known as MAKOplasty®, today announced its operating results for its second quarter ended June 30, 2010.

Researchers analyze benefits of platelet-rich plasma therapy for tennis elbow

A procedure intended to help heal musculoskeletal injuries called platelet-rich plasma therapy, or P.R.P., has created a big buzz in sports medicine and the media in recent years. Tiger Woods reportedly received the procedure for a sore knee and Pittsburgh Steelers' Hines Ward used it for a sprained knee ligament just before playing a key role in the team's 2009 Super Bowl victory.

Study explores role of proline containing peptides in inhibiting anti-apoptotic function of XIAP

Basic and translational research on cancer, and development of new cancer therapeutics, has focused on different aspects of cancer cellular function. One area of focus is the life and death of a cancer cell. Apoptosis, also known as programmed cell death, is a fundamental process of cells including cancer cells. The signal transduction pathways of apoptosis involve many different proteins and their interactions with each other.

Read more News

› Verified 8 days ago


Internal Medicine Doctors in Las Vegas, NV

Dr. Arshi A. Quadeer, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 2545 S Bruce St Ste 200, Las Vegas, NV 89169
Phone: 702-732-2438    Fax: 702-737-5043
Cherie Lin, D.O.
Hematology & Oncology
Medicare: Not Enrolled in Medicare
Practice Location: 3006 S Maryland Pkwy, Suite 400, Las Vegas, NV 89109
Phone: 702-369-5582    Fax: 702-369-1533
Michael M Lee, MD
Hematology & Oncology
Medicare: Medicare Enrolled
Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102
Phone: 702-921-6823    Fax: 702-549-5240
Henry Palangdao Igid, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 653 N Town Center Dr Ste 402, Las Vegas, NV 89144
Phone: 702-243-7200    Fax: 702-243-7235
Ian Adrian Fanoga Frani, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102
Phone: 702-383-2000    Fax: 702-383-3875
Sein Tun, DO
Hematology & Oncology
Medicare: Medicare Enrolled
Practice Location: 620 Shadow Ln, Las Vegas, NV 89106
Phone: 702-388-4000    
Berge Jack Dadourian, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 400 S Rampart Blvd, Suite 240, Las Vegas, NV 89145
Phone: 702-906-1100    Fax: 702-906-1110

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.